Evidence map›Paper›PMID 38817008›Full record

ReviewRecent patents on biotechnology2024

Bioprospecting of Metabolites from Actinomycetes and their Applications.

Syed Khalida Izhar, Shareen Fatima Rizvi, Uzma Afaq, Faria Fatima, Saba Siddiqui

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Assessing hydrocarbon degradation capacity ofFrontiers in microbiology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Syed Khalida IzharDepartment of Biosciences, Integral University, Lucknow, 226026, India.
Shareen Fatima RizviProtein Research Laboratory, Department of Biosciences, Integral University Lucknow, 226026, India.
Uzma AfaqDepartment of Biosciences, Integral University, Lucknow, 226026, India.
Faria FatimaIntegral Institute of Agricultural Science and Technology, Integral University, Lucknow, 226026, India.
Saba SiddiquiIntegral Institute of Agricultural Science and Technology, Integral University, Lucknow, 226026, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinomycetes are present in various terrestrial and aquatic habitats, predominantly in the soil rhizosphere, encompassing marine and freshwater ecosystems. These microorganisms exhibit characteristics that resemble both bacteria and fungi. Numerous actinomycetes exhibit a mycelial existence and undergo significant morphological transformations. These bacteria are widely recognized as biotechnologically significant microorganisms utilized for the production of secondary metabolites. In all, over 45% of all bioactive microbial metabolites are produced by actinomycetes, which are responsible for producing around 10,000 of them. The majority of actinomycetes exhibit substantial saprophytic characteristics in their natural environment, enabling them to effectively decompose a diverse range of plant and animal waste materials during the process of decomposition. Additionally, these organisms possess a sophisticated secondary metabolic system, which enables them to synthesize almost two-thirds of all naturally occurring antibiotics. Moreover, they can create a diverse array of chemical compounds with medical or agricultural applications, including anticancer, antiparasitic, and antibacterial agents. This review aims to provide an overview of the prominent biotechnological domains in which actinobacteria and their metabolites demonstrate noteworthy applicability. The graphical abstract provides a preview of the primary sections covered in this review. This paper presents a comprehensive examination of the biotechnological applications and metabolites of actinobacteria, highlighting their potential for patent innovations.

Indexed as

ActinobacteriaBioprospectingPatents as TopicAnti-Bacterial AgentsBiotechnologySecondary MetabolismSoil MicrobiologyAnti-Bacterial AgentsActinomycetesapplicationsbioprospecting of metabolites.medicinessecondary metabolitessustainability

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.